TP53 and ovarian cancer: Our results indicated that limonin reversed the resistance to cisplatin in ovarian cancer cells via activation of p53-mediated apoptosis (Fig. 7), suggesting that limonin may potentially be a novel strategic drug for chemotherapy of mucinous-type ovarian cancer.